Sector revisions Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate Other stock markets 07:24:41 2026-07-08 am EDT			5-day change	1st Jan Change
198.58 ^EUR	-1.35%		+0.86%	+16.06%

Jul. 07	Evercore ISI Adjusts Price Target on Charles River Laboratories International to $260 From $220	MT
Jul. 01	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
LONZA GROUP AG		23
REVOLUTION MEDICINES, INC.		22
BEONE MEDICINES AG		27
IQVIA HOLDINGS INC.		19
CELLTRION, INC.		24
ASCENDIS PHARMA A/S	-	18
MEDPACE HOLDINGS, INC.		12
IONIS PHARMACEUTICALS, INC.		22
EUROFINS SCIENTIFIC SE		14
ICON PUBLIC LIMITED COMPANY		16
ABIVAX		6
BIO-TECHNE CORPORATION		12
TEMPUS AI, INC.		16
APOGEE THERAPEUTICS, INC.		12
KYMERA THERAPEUTICS, INC.		21
ALKERMES PLC		16
PRAXIS PRECISION MEDICINES, INC.		18
PROTAGONIST THERAPEUTICS, INC.		13
QIAGEN N.V.		14
Average		17
Weighted average by Cap.		19